hims semaglutide side effects Novo Nordisk calls out dangers of compounded GLP-1s in new ad Novo, Lilly sputter as Hims

If you have commercial GLP-1 coverage, you are welcome to join our monthly GLP-1 program to obtain concierge weight loss coverage with frequent check-ins, close monitoring, and body composition scans to monitor progress

Ideal Candidates for Medical Weight Loss Not every patient is an automatic candidate for injectable therapy, which makes evaluation a critical first step

The medication is HSA/FSA eligible and available in all 50 states without insurance

And the rebound question matters: research shows 60-163% of weight lost on GLP-1 agonists (conventional dosing) is regained after discontinuation, bringing its own hormonal recalibration that most prescribers are not preparing patients for

Yes, GLP-1 receptor agonists and thyroid medications can generally be used together, but concurrent use requires clinical awareness and provider monitoring